Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments

Author:

Alrushaid Noor12,Khan Firdos Alam2ORCID,Al-Suhaimi Ebtesam3ORCID,Elaissari Abdelhamid1ORCID

Affiliation:

1. Universite Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France

2. Department of Stem Cell Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia

3. Biology Department, College of Science, Institute of Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia

Abstract

Worldwide, colon cancer is the third most frequent malignancy and the second most common cause of death. Although it can strike anybody at any age, colon cancer mostly affects the elderly. Small, non-cancerous cell clusters inside the colon, commonly known as polyps, are typically where colon cancer growth starts. But over time, if left untreated, these benign polyps may develop into malignant tissues and develop into colon cancer. For the diagnosis of colon cancer, with routine inspection of the colon region for polyps, several techniques, including colonoscopy and cancer scanning, are used. In the case identifying the polyps in the colon area, efforts are being taken to surgically remove the polyps as quickly as possible before they become malignant. If the polyps become malignant, then colon cancer treatment strategies, such as surgery, chemotherapy, targeted therapy, and immunotherapy, are applied to the patients. Despite the recent improvements in diagnosis and prognosis, the treatment of colorectal cancer (CRC) remains a challenging task. The objective of this review was to discuss how CRC is initiated, and its various developmental stages, pathophysiology, and risk factors, and also to explore the current state of colorectal cancer diagnosis and treatment, as well as recent advancements in the field, such as new screening methods and targeted therapies. We examined the limitations of current methods and discussed the ongoing need for research and development in this area. While this topic may be serious and complex, we hope to engage and inform our audience on this important issue.

Publisher

MDPI AG

Subject

General Medicine

Reference89 articles.

1. Olovo, C.V., Huang, X., and Zheng, X. (2021). Faecal microbial biomarkers in early diagnosis of colorectal cancer. J. Cell. Mol. Med.

2. Pavitra, E., Dariya, B., Srivani, G., Kang, S.M., Alam, A., Sudhir, P.R., Kamal, M.A., Raju, G.S.R., Han, Y.K., and Lakkakula, B.V.K.S. (2021). Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin. Cancer Biol.

3. (2023, July 30). Data visualization Tools for Exploring the Global Cancer Burden in 2020. Available online: https://gco.iarc.fr/today/.

4. Predictive Value of Circulating Tumor Cells in Prognosis of Stage III/IV Colorectal Cancer after Oxaliplatin-based First-line Chemotherapy;Yu;In Vivo,2022

5. The American Cancer Society Medical and Editorial Content Team (ACSMECT) (2020, June 29). American Cancer Society. Cancer.Org. Available online: https://www.cancer.org/cancer/colon-rectal-cancer/causes-risks-prevention/risk-factors.html.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3